top of page

2024 GI Symposium

NCSCG 2024 GI Symposium web banner_generic_1200x700_v1.png


Program Overview

The joint providership of Medical Education Resources (MER) and Northern California Society for Clinical Gastroenterology (NCSCG) is excited to propose 21st Annual NCSCG GI Symposium, a comprehensive update on gastrointestinal (GI) and hepatology diseases.

Target Audience

Health care professionals (HCPs), including gastroenterologists, hepatologists, nurse practitioners, physician assistants, and nurses.


Educational Objectives

Upon completion of this activity, participants should be able to:

  • Describe current guidelines for the treatment and management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders

  • Employ an evidence-based approach to the management of CLD and GI disorders

  • Optimize treatment results for patients with CLD and GI disorders utilizing new therapies


In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Northern California Society for Clinical Gastroenterology (NCSCG). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit
Medical Education Resources designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Designation

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Northern California Society for Clinical Gastroenterology, and/or Salix Pharmaceuticals. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Fee Information


Jointly provided by the Medical Education Resources and the Northern California Society for Clinical Gastroenterology (NCSCG).

Supported by an educational grant from Salix Pharmaceuticals.

bottom of page